Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

NICE rejects Takeda Crohn’s disease drug

December 23, 2014 Sales and Marketing Crohn’s disease, Entyvio, NHS, NICE, Takeda, crohn's disease, vedolizumab

Takeda has seen its treatment for people with Crohn’s disease Entyvio rejected by NICE in an initial appraisal. The healthcare …
News

EMA ramps up adaptive pathways pilot

December 23, 2014 Manufacturing and Production, Research and Development, Sales and Marketing EMA, adaptive pathways, drugs, regulator

Six medicines have been selected to move to the next stage of the EMA’s adaptive pathways pilot project, to explore …
News

New hope through Ebola vaccine trial

December 23, 2014 Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, US, marburg, uganda

A report in the Lancet medical journal has highlighted a treatment found to be well-tolerated in healthy Ugandan adults during …
News

New chairman for Egenix

December 23, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing egenix, lionel goldfrank

Lionel Goldfrank has been elected to sit on the board of the US-based biotech firm Egenix. Goldfrank is to succeed Donald …
Appointment

Cubist boosts antibiotics market presence

December 22, 2014 Sales and Marketing Antibiotics, Zerbaxa, antimicrobial resistance, bacteria, cubist, infections, infectious diseases

Cubist has followed-up its successful European approval for a new antibiotic by winning an endorsement by the US FDA. The …
News

Lilly to market stomach cancer drug in Europe

December 22, 2014 Sales and Marketing Eli Lilly, Europe, FDA, US, cyramza, ramucirumab, stomach cancer

Eli Lilly has been granted permission by the European Commission to market Cyramza in Europe. Lilly’s Cyramza (ramucirumab) is the …
News

Abbvie Hep C drug gains FDA approval

December 22, 2014 Sales and Marketing AbbVie, FDA, Gilead, Viekira Pak, dasabuvir, harvoni, hepatitis, hepatits C

Abbvie has gained sign-off for its rival treatment to challenge Gilead’s dominance of the growing market for new hepatitis C …
News

Chiesi gets first-ever European stem cell nod

December 19, 2014 Sales and Marketing Chiese, Chiesi, EMA, Holoclar, LSCD, MHRA, Stem cells, orexigen

Chiesi has received the first approval for an advanced therapy medicinal product containing stem cells for use in Europe. The …
News

Visions for the future: FT pharma and biotech event

December 19, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, ABPI, Deloitte, Medidata, Whitehead, financial ties, freeman, ft pharma

The FT Global Pharmaceutical and Biotechnology Conference held in London recently asked: “What will the life science company of the …
Feature

Merck acquires Swiss firm OncoEthix

December 19, 2014 Sales and Marketing Cancer, FDA, Merck, OTX015, cubist, keytruda, oncoethix, pembrolizumab

Hot on the heals of its Cubist buyout Merck has confirmed the acquisition of OncoEthix, a Swiss based firm which …
News

Roche dealt with two late-stage blows

December 19, 2014 Sales and Marketing Alzheimer's, Alzheimer’s, Cancer, Kadcyla, Perjeta, Roche, Xeloda, trastuzumab emtansine

Swiss giant Roche’s breast cancer treatment Kadcyla has failed to meet its primary endpoint and its investigational Alzheimer’s treatment trial …
News

GSK shingles vaccine on form

December 19, 2014 Sales and Marketing GSK, HZ/su, Merck, Vaccine, Zostavax, shingles

GlaxoSmithKline will be celebrating following the successful Phase III study of its shingles vaccine HZ/su that has met its primary …
News

NHS not au fait with mobile-savvy patients

December 19, 2014 Medical Communications, Sales and Marketing NHS, app, digital, health, mobile, smartphones, wearables

The NHS is failing to keep up with its digital generation of patients, a recent study has found.  Despite a …
News

Takeda takes senior head from Sanofi

December 19, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Takeda, andrew plump

Dr Andrew Plump will be joining Takeda in February from Sanofi to lead its global R&D operations as chief medical …
Appointment

New Lyrica formulation effective in trials

December 19, 2014 Sales and Marketing HIV, Lyrica, Pfizer, pain, pregabalin, shingles

Pfizer has reported positive Phase III results for a new formulation of its painkiller Lyrica. In the study, a controlled-release …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026